Thermo Fisher Scientific (TMO) Net Margin (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Net Margin for 18 consecutive years, with 14.65% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Margin fell 25.0% year-over-year to 14.65%; the trailing twelve-month figure through Jun 2026 stood at 15.19% (down 4.0% YoY), and the FY2025 full-year result was 15.17%, up 40.0% from the prior year.
• Net Margin fell to 14.65% in Q2 2026 per TMO's latest filing, from 15.12% in the prior quarter.
• Across five years, Net Margin topped out at 18.74% in Q2 2022 and bottomed at 12.04% in Q2 2023.
• Historically, Net Margin has averaged 14.82% across 5 years, with a median of 14.79% in 2025.
• The widest YoY moves for Net Margin: up 222 bps in 2023, down 671 bps in 2023.
• Over 5 years, Net Margin stood at 13.76% in 2022, then climbed by 9 bps to 14.97% in 2023, then increased by 7 bps to 16.06% in 2024, then grew by 2 bps to 16.37% in 2025, then slipped by 11 bps to 14.65% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 14.65%, 15.12%, and 16.37% for Q2 2026, Q1 2026, and Q4 2025 respectively.